{"retracted":false,"update":{"timestamp":1480291200000,"doi":"10.1007/s12185-016-2155-3","type":"correction"},"doi":"10.1007/s12185-016-2097-9","journal":"International Journal of Hematology","publisher":"Springer Nature","title":"Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden"}
